JW Life Science Corp
234080
Company Profile
Business description
JW Life Science Corp develops and produces infusion solutions. Its products contents amino acids, lipids, proteins, vitamins, and minerals to patients.
Contact
28, Hanjin 1-gil
Songak-eup, Dangjin-si
Chungcheongnam-do
Seoul343-823
KORT: +82 413517600
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2025
Employees
325
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,421.70 | 21.90 | 0.26% |
| CAC 40 | 7,694.44 | 67.60 | 0.89% |
| DAX 40 | 23,352.69 | 236.73 | 1.02% |
| Dow JONES (US) | 41,603.66 | 489.69 | 1.19% |
| FTSE 100 | 8,531.61 | 27.72 | -0.32% |
| HKSE | 22,775.92 | 84.04 | 0.37% |
| NASDAQ | 18,036.55 | 298.39 | 1.68% |
| Nikkei 225 | 36,928.63 | 148.97 | 0.41% |
| NZX 50 Index | 12,467.03 | 29.86 | -0.24% |
| S&P 500 | 5,699.22 | 67.94 | 1.21% |
| S&P/ASX 200 | 8,191.70 | 13.40 | 0.16% |
| SSE Composite Index | 3,352.00 | 9.33 | 0.28% |